Phase I dose-finding and safety study of AZD8931 with Oxaliplatin and Capecitabine chemotherapy in patients with Oesophago-gastric adenocarcinoma: the randomised expansion phase of the DEBIOC trial
Thomas A., Virdee PS., Eatock M., Lord S., Falk S., Anthoney DA., Turkington R., Goff M., Elhussein L., Collins L., Moschandreas J., Middleton M.